跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CO-DIOVAN 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CO-DIOVAN 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
CO-DIOVAN 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Melyfarma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 3, 2024
Approval ID
c3b8ed6e0ee7c4af
Company
Melyfarma S.L.
Type
Standard
Approval Details
Approval Id
c3b8ed6e0ee7c4af
Drug Cima Aemps Name
CO-DIOVAN 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
3400938156652IP
Holder Company Name
Melyfarma S.L.
Marketing Company Name
Melyfarma S.L.
Authorization Date
2024-06-03
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
160 mg valsartan; 12.5 mg hidroclorotiazida
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Melyfarma S.L.
Active Ingredients
VALSARTAN
160 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 3, 2024
Approval ID
c3b8ed6e0ee7c4af
Type
Standard
Back to CIMA-AEMPS Approvals